Form 4: Applied Therapeutics Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Riccardo Perfetti, Chief Medical Officer of Applied Therapeutics, sold 10,366 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On March 4, 2025, Riccardo Perfetti, the Chief Medical Officer of Applied Therapeutics, Inc., sold 10,366 shares of the company's common stock.
- The shares were sold at a price of $0.44 per share.
- This transaction was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
- Following the transaction, Perfetti directly owns 890,409 shares of Applied Therapeutics common stock.
- The sale was not a discretionary transaction but rather a 'sell to cover' transaction to satisfy tax obligations.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation plans and are not necessarily indicative of a negative outlook on the company.
Stakeholder Impact
- The sale of shares by an officer could have a minor impact on shareholder perception, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| December 22, 2024 | Date of execution of Power of Attorney. |
| March 4, 2025 | Date of stock sale transaction. |
| March 6, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.